Brevan Howard Capital Management’s Medifast MED Stock Holding History

Brevan Howard Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$159K	Buy	+15,025	New	+$173K	﹤0.01%	1937
2026 Q1	–	Sell	-13,125	Closed	-$140K	–	2343
2025 Q4	$140K	Buy	+13,125	New	+$157K	﹤0.01%	1644
2023 Q4	–	Sell	-5,271	Closed	-$395K	–	1070
2023 Q3	$395K	Hold	5,271	–	–	0.01%	203
2023 Q2	$486K	Buy	+5,271	New	+$469K	0.01%	137

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brevan Howard Capital Management's MED Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Medifast (MED) in Q2 2026: 15,025 shares worth $159K. The stake represents ﹤0.01% of the portfolio and ranks #1937 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in MED as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in MED in Q2 2023 and has held it in 4 quarters since. The position peaked at $486K in Q2 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Brevan Howard Capital Management held 15,025 shares of Medifast worth $159K as of Q2 2026.
Medifast was a new Brevan Howard Capital Management position in Q2 2026.
Medifast made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1937 holding.
Brevan Howard Capital Management first reported a position in Medifast in Q2 2023 and has held it in 4 quarters since.
Brevan Howard Capital Management's Medifast position peaked at $486K in Q2 2023.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.